Testing effectiveness (Phase 2)UnknownNCT00005939What this trial is testingBrachytherapy in Treating Patients With Recurrent Prostate CancerWho this might be right forProstate Cancer Center for Molecular Medicine
Testing effectiveness (Phase 2)Study completedNCT00817739What this trial is testingIntermittent Hormonal Therapy With Leuprorelin and Flutamide in the Treatment of Stage D2 or TxNxM1b,cWho this might be right forProstatic Neoplasms Takeda 341
Testing effectiveness (Phase 2)Enrolling By InvitationNCT04145375What this trial is testingContinuation Protocol for ZEN003694 in Patients Experiencing Clinical Benefit While Enrolled in a ZEN003694 ProtocolWho this might be right formCRPC Zenith Epigenetics 40
Not applicableUnknownNCT03692000What this trial is testingDesigning a Digital Tool to Support Healthy Lifestyle in Men With Prostate CancerWho this might be right forHealth LiteracyComputer LiteracyProstate Cancer Danish Cancer Society 55
Testing effectiveness (Phase 2)Study completedNCT03001895What this trial is testingCorrelation Between SUV on 18F-DCFPyL PET/CT and Gleason Score in Prostate CancerWho this might be right forProstate Cancer Sir Mortimer B. Davis - Jewish General Hospital 120
Testing effectiveness (Phase 2)UnknownNCT00546039What this trial is testingSynthetic Genistein (BONISTEIN™) in Patients Who Are Undergoing Surgery for Prostate CancerWho this might be right forProstatic Neoplasms University Hospital, Aker 47
Testing effectiveness (Phase 2)UnknownNCT02691975What this trial is testingA Safety and Efficacy Study of SHR3680 in Metastatic Castration-Resistant Prostate Cancer PatientsWho this might be right forHormone Refractory Prostate CancerMetastatic Prostate Carcinoma Jiangsu HengRui Medicine Co., Ltd. 197
Very early researchActive Not RecruitingNCT05851365What this trial is testingMagnetic Resonance (MR) Imaging With Hyperpolarized Bicarbonate (13C) to Measure Tissue pH in Prostate CancerWho this might be right forProstate CancerLocalized Prostate Carcinoma Robert Flavell, MD, PhD 1
Not applicableStudy completedNCT02941029What this trial is testingRADTOX: Measuring Radiation Toxicity Using Circulating DNAWho this might be right forProstate Cancer University of Florida 68
Early research (Phase 1)Study completedNCT00058253What this trial is testingCombination Chemotherapy in Treating Patients With Metastatic or Unresectable Solid TumorsWho this might be right forRecurrent Prostate CancerStage IV Prostate CancerUnspecified Adult Solid Tumor, Protocol Specific National Cancer Institute (NCI) 80
Not applicableLooking for participantsNCT03344835What this trial is testingHong Kong Prostate Cancer Study Group DatabaseWho this might be right forProstate Cancer Chinese University of Hong Kong 15,000
Not applicableEnded earlyNCT05709535What this trial is testingPSMA-PET/CT RegistryWho this might be right forProstate Cancer AHS Cancer Control Alberta 128
Large-scale testing (Phase 3)Study completedNCT00548600What this trial is testingRadical Radiotherapy by External Beam Radiation Versus Radical Radiotherapy With Temporary Iridium Implant Plus External Beam Radiation in Carcinoma of the ProstateWho this might be right forProstate Cancer Ontario Clinical Oncology Group (OCOG) 112
Not applicableUnknownNCT02809495What this trial is testingDigital Application Usage for Adherence of Patients Undergoing Robotic Assisted Radical Prostatectomy Following Oncological and Postoperative Functional OutcomesWho this might be right forthe Focus of This Study is to Develop an Application for Postoperative Follow-up of Patients With Prostate Cancer University of Sao Paulo General Hospital 100
Testing effectiveness (Phase 2)UnknownNCT00121095What this trial is testingStudy of Samarium Sm-153 Lexidronam Combined With Docetaxel for Patients With Prostate CancerWho this might be right forProstatic Neoplasms Cytogen Corporation 69
Not applicableTemporarily pausedNCT03734575What this trial is testingClariCore System Used in Transperineal Prostate BiopsyWho this might be right forProstate Cancer Precision Biopsy, Inc. 60
Testing effectiveness (Phase 2)Ended earlyNCT00104130What this trial is testingStudy of KOS-862 (Epothilone D) in Metastatic Prostate CancerWho this might be right forProstate Cancer Bristol-Myers Squibb 53
Testing effectiveness (Phase 2)Study completedNCT01607879What this trial is testingUse of β-hydroxy-β-methylbutyrate to Counteract Muscle Loss in Men With Prostate Cancer on Androgen AblationWho this might be right forProstate Cancer Medical College of Wisconsin 48
Testing effectiveness (Phase 2)Study completedNCT05265988What this trial is testingMultiparametric Assessment of Bone Response in mCRPC Patients Treated With CabozantinibWho this might be right forCarcinoma Prostate Alfredo Berruti 32
Not applicableLooking for participantsNCT02724670What this trial is testingStudy of MR-based IGRT for Prostate CancerWho this might be right forProstate Cancer University Hospital Tuebingen 78